Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation with clinical liver and ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

Preclinical results indicate new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue.

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...